A longterm endoscopic evaluation of patients with arthritis treated with nabumetone vs naproxen.

Abstract

Nabumetone appears to have a significantly lower ulcerogenic potential than naproxen over a 5-year period, and there is a trend toward better tolerability as measured by withdrawals for adverse experiences.